Table of Contents
A prior art search Barcelona litigation teams can rely on has to be built for Spain’s leading patent forum — and for a rule that surprises many foreign clients: Spain is not in the Unified Patent Court. Barcelona is the busiest patent-litigation venue in the country, its specialised commercial courts hear the pharma and generics fights that define the Spanish docket, and every one of those cases is decided nationally, under Spanish law, entirely outside the UPC. PerspireIP builds invalidity-grade searches for the accused parties and counsel fighting those patents before the Barcelona courts and at the EPO.
Why a prior art search Barcelona case turns on venue
Barcelona is Spain’s leading patent-litigation venue, and a prior art search Barcelona counsel can rely on has to be built for that forum. Not every commercial court in the city hears patent cases: by a 2011 agreement of the General Council of the Judiciary (CGPJ), Commercial Courts No. 1, No. 4 and No. 5 of Barcelona were specialised to hear patent and design disputes, while other Barcelona commercial courts take trademark matters. Appeals go to Section 15 of the Barcelona Court of Appeal (Audiencia Provincial de Barcelona), the specialised commercial and industrial-property appellate bench.
That concentration of expertise is why so many of Spain’s most important patent fights are filed in Barcelona rather than in Madrid or Valencia, the two other cities with specialised patent courts. Judges here routinely apply the EPO problem-and-solution approach to inventive step, so the invalidity evidence you put before them has to be structured the way they read it. In a validity fight the case turns on the prior art, and the search is the engine that drives it.
- Barcelona Commercial Courts No. 1, No. 4 and No. 5 — specialised first-instance courts for patent and design disputes
- Audiencia Provincial de Barcelona, Section 15 — the specialised commercial and IP court of appeal
- EPO Opposition Division — central attack on a European patent within nine months of grant
- OEPM — the Spanish office that grants and registers the national patents enforced in Barcelona
Spain sits outside the UPC — enforcement and invalidity are national
Here is the local fact that shapes every strategy: Spain has not joined the Unified Patent Court. Along with Croatia, it stayed outside both the UPC and the unitary patent, so there is no UPC route to enforce or to revoke a patent in Spain. A European patent takes effect in Spain only when it is validated as a national Spanish right, and from that moment it lives or dies under Spanish law before the Spanish courts.
For an accused party this changes the map completely. A patentee that owns a unitary patent covering most of the EU still needs a separate, classical Spanish validation to reach the Spanish market, and that Spanish patent can be attacked only in Spain. A UPC revocation, however sweeping, does not touch it. The fight over the Spanish designation is fought in Barcelona, on Spanish prior-art rules — not in Munich, Paris or Milan.
That is a strategic gap and an opportunity. Because the Spanish right stands on its own, a Barcelona nullity action can succeed even where a parallel UPC or German case is going the other way, provided the prior art is there. It also means the search has to be scoped to Spanish and EPC standards specifically, rather than assumed to travel automatically from another forum.
Two routes to attack a patent in Spain: nullity and EPO opposition
An accused infringer in Barcelona has two realistic ways to knock out the patent being asserted, and neither is the UPC. The first is a Spanish nullity action — brought as a standalone claim or, more often, as a counterclaim to an infringement suit — before the specialised Barcelona commercial court. The second is opposition at the European Patent Office, a central attack that must be filed within nine months of grant and can revoke the European patent in every designated state at once.
The grounds overlap but the timing does not. EPO opposition is a short window that closes nine months after grant; a Spanish nullity action can be brought later, throughout the life of the patent. Because Spain is outside the UPC, there is no third, pan-European revocation option here — the Spanish designation must be attacked in Spain. One rigorous invalidity search, charted claim by claim, can feed both a Barcelona nullity counterclaim and an EPO opposition at the same time.
- Spanish nullity action — standalone or counterclaim before Barcelona Commercial Court No. 1, 4 or 5, revoking the Spanish patent
- EPO opposition — central attack within nine months of grant, decided on novelty and inventive step for all designated states
- No UPC route — Spain never joined, so the Spanish right can only be challenged nationally
Law 24/2015 and what changed for Spanish validity
The rules the Barcelona courts apply were reshaped by the Spanish Patent Act, Law 24/2015, which entered into force on 1 April 2017. It replaced the old optional-examination system with a single grant procedure that includes full substantive examination for novelty and inventive step, so newer Spanish patents arrive already tested — which raises the bar for the prior art you need to overturn them.
The Act also codified the grounds for nullity in Article 102: lack of novelty, lack of inventive step or industrial applicability, insufficient disclosure, added matter beyond the application as filed, unlawful extension of the protection conferred, and lack of entitlement. In practice the overwhelming majority of nullity attacks succeed or fail on novelty and, above all, inventive step — which is precisely where a well-dated prior-art reference does its work.
Spanish validity law also tracks EPO jurisprudence closely. In April 2025 the Spanish Supreme Court became the first European supreme court to adopt, in main proceedings, the plausibility test from EPO Enlarged Board decision G 2/21, applying it to both inventive step and sufficiency of disclosure. For a search that means the public-availability date and the technical teaching of every reference must be pinned down with evidence, not assumed.
Barcelona’s pharma and generics battleground
Barcelona is the heart of Spain’s pharmaceutical industry, and pharma is the dominant theme of its patent docket. Catalonia is home to a dense cluster of drug companies — names such as Grifols, Almirall, Esteve, Ferrer, Reig Jofre and Uriach — alongside the generics manufacturers that repeatedly clear a path to market by challenging originator patents. That mix makes the Barcelona courts Spain’s busiest forum for pharma and generics disputes.
These cases are frequently fought at speed through preliminary injunctions. Barcelona commercial courts have granted and lifted ex parte and inter partes injunctions in high-profile generics battles — over molecules such as fingolimod, dimethyl fumarate and apixaban — where a product launch can be blocked or freed in a matter of weeks. When the injunction hangs on the validity of the patent, the invalidity search has to be ready before the hearing, not after it.
Pharma and chemistry prior art also lives in a different place than technology art. The decisive reference is often a journal paper indexed by Chemical Abstracts (CAS), a sequence or structure record for a biologic, or an older or abandoned patent family argued as an obviousness combination. We search those sources directly and prove each one was public before the priority date the claim actually relies on.
SEAT, chemicals and food-tech: where Barcelona’s other prior art lives
Barcelona’s economy is far wider than pharma, and so is its prior art. Martorell, just outside the city, is home to SEAT and Cupra — Spain’s largest automotive plant and part of the Volkswagen Group — anchoring a cluster of automotive and components suppliers whose patents cover mechanics, electronics and, increasingly, electric-vehicle and connectivity technology.
The region also carries deep chemicals and food-technology industries, and each year the Mobile World Congress makes Barcelona a global centre for mobile, 5G and connected-device technology, where standard-essential and telecoms patents are asserted too. Each field hides its prior art somewhere different: SAE and engineering standards for automotive, ETSI and 3GPP contributions for telecoms, and trade and technical literature for food tech and chemicals.
A credible invalidity search reaches into all of them. We match the strategy to the technology — patent and non-patent literature for chemistry, standards-body submissions and dated technical disclosures for telecoms and automotive, and the trade press and product manuals that often carry the earliest public disclosure of a food-tech or mechanical feature.
How PerspireIP builds a prior art search Barcelona case can rely on
Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date printed on the cover. We run patent and non-patent-literature searching in parallel, then build claim charts a Barcelona commercial court judge or an EPO Opposition Division can follow line by line.
- Claim charting mapped to novelty and inventive step under the EPC and Article 102 of Law 24/2015
- Deep retrieval across CAS, peer-reviewed journals, sequence databases, standards-body submissions and older patent families
- Public-availability dating for every reference, evidenced and ready to withstand the G 2/21 plausibility test
- Prior art sized to your forum — a Barcelona nullity action or the nine-month EPO opposition window
- A written invalidity analysis and reference packages ready for the Spanish court or the EPO
We work alongside your Spanish and European counsel as a specialist search partner, deliver to Barcelona court and nine-month EPO opposition deadlines, and keep every engagement confidential. Whether you are a generics or biosimilar entrant clearing a path, an accused manufacturer facing an assertion, or litigation counsel preparing a Spanish nullity defence, we scale to fit — a single search, a multi-patent campaign or ongoing support. Send us the patent number and your key dates, and we will scope a prior art search Barcelona project within one business day.
IP Landscape & Resources in Barcelona
Key intellectual-property authorities and venues relevant to Barcelona:
- OEPM (Oficina Española de Patentes y Marcas) — the Spanish Patent and Trademark Office; the only body that grants and registers the national patents enforced in Barcelona
- European Patent Office (EPO) — grants European patents and runs post-grant opposition, a central attack filed within nine months of grant
- Consejo General del Poder Judicial (CGPJ) — the Spanish judiciary body whose agreements specialised Barcelona Commercial Courts No. 1, 4 and 5 for patent cases
Request a Prior Art Search in Barcelona
Request a Prior Art Search in Barcelona
Get an invalidity-grade prior-art search built for a Spanish nullity action before the Barcelona commercial courts or a nine-month EPO opposition — tuned for pharma, generics, chemistry and telecoms claims, and scoped for a country that sits outside the UPC. Send us the patent number and your key dates, and we will scope a prior art search Barcelona project within one business day.
Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.
Frequently Asked Questions
Why isn’t a Barcelona patent case heard by the Unified Patent Court?
Because Spain never joined the UPC. Along with Croatia, Spain stayed outside both the Unified Patent Court and the unitary patent, so there is no UPC route to enforce or to revoke a patent in Spain. A European patent takes effect in Spain only when it is validated as a national Spanish right, and that right can be litigated only before the Spanish courts — for the most important patent disputes, the specialised commercial courts of Barcelona. A UPC revocation does not touch the Spanish designation.
Which Barcelona courts hear patent cases?
Not every commercial court in the city. By a 2011 agreement of the General Council of the Judiciary (CGPJ), Barcelona Commercial Courts No. 1, No. 4 and No. 5 were specialised to hear patent and design disputes, while other commercial courts take trademark matters. Appeals go to Section 15 of the Barcelona Court of Appeal (Audiencia Provincial de Barcelona), the specialised commercial and industrial-property appellate bench. Barcelona is Spain’s busiest patent-litigation venue, ahead of Madrid and Valencia.
Spanish nullity action or EPO opposition — which route invalidates the patent?
They do different things and run on different clocks. A Spanish nullity action — standalone or as a counterclaim before the Barcelona commercial court — revokes the Spanish patent and can be brought throughout its life. EPO opposition is a central attack that must be filed within nine months of grant and can revoke the European patent in all designated states at once, on novelty and inventive step. Because Spain is outside the UPC there is no pan-European revocation option here. One prior art search can feed both routes.
Where does pharma and generics prior art for a Barcelona case actually live?
Often outside patent databases. Barcelona is the centre of Spain’s pharma and generics litigation, and the decisive art for a chemistry or life-science claim frequently sits in the journal literature indexed by Chemical Abstracts (CAS), in sequence and structure databases for biologics, and in older or abandoned patent families argued as inventive-step combinations. We search those sources directly and prove each reference was public before the claim’s priority date — critical now that Spain applies the G 2/21 plausibility test.